In vitro antimicrobial activity of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA

Veterinary Dermatology

Volumn 21, Issue 3, 2010, Pages 282-286

  Guardabassi, Luca ^a   Ghibaudo, Giovanni ^b   Damborg, Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Clinica Veterinaria Malpensa di Samarate ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; EDETIC ACID; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; DRUG EFFECT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; OTITIS; PROTEUS INFECTION; PROTEUS MIRABILIS; PSEUDOMONAS INFECTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS; DOG DISEASES; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; VETERINARY;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; DOG DISEASES; DOGS; EDETIC ACID; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OTITIS; PROTEUS INFECTIONS; PROTEUS MIRABILIS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

CANIS FAMILIARIS; CORYNEBACTERIUM; CORYNEBACTERIUM AURISCANIS; ESCHERICHIA COLI; MALASSEZIA PACHYDERMATIS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS; STREPTOCOCCUS; STREPTOCOCCUS CANIS;

EID: 77954037159     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2009.00812.x     Document Type: Article

References (22)

1. Moodley A, Stegger M, Bagcigil AF. spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland. Journal of Antimicrobial Chemotherapy 2006, 58:1118-23.
2. Loeffler A, Linek M, Moodley A. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Veterinary Dermatology 2007, 18:412-21.
3. Moodley A, Stegger M, Ben Zakour NL. Tandem repeat sequence analysis of staphylococcal protein A (spa) gene in methicillin-resistant Staphylococcus pseudintermedius. Veterinary Microbiology 2008, 135:320-6.
4. Guardabassi L, Houser GA, Frank LA. Guidelines for antimicrobial use in small animals. Guide to Antimicrobial Use in Animals 2008, 183-206. Guardabassi L, Jensen LB, Hilde K. In, eds, Oxford, Blackwell Publishing
5. Trott DJ, Moss SM, See AM. Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine. Australian Veterinary Journal 2007, 85:464-6.
6. Morris DO. Medical therapy of otitis externa and otitis media. Veterinary Clinics of North America: Small Animal Practice 2004, 34:541-5.
7. Kuyyakanond T, Quesnel LB. The mechanism of action of chlorhexidine. FEMS Microbiology Letters 1992, 79:211-5.
8. Simor AE, Phillips E, McGeer A. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clinical Infectious Diseases 2006, 44:178-85.
9. Vaara M. Agents that increase the permeability of the outer membrane. Microbiology and Molecular Biology Reviews 1992, 56:395-411.
10. Lambert RJW, Hanlon GW, Denyer SP. The synergistic effect of EDTA/antimicrobial combinations on Pseudomonas aeruginosa. Journal of Applied Microbiology 2004, 96:244-53.
11. Farca AM, Piromalli G, Maffei F. Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis. Journal of Small Animal Practice 1997, 38:243-5.
12. Swinney A, Fazakerley J, McEwan N. Comparative in vitro antimicrobial efficacy of commercial ear cleaners. Veterinary Dermatology 2008, 19:373-9.
13. Devriese LA, Hermans K, Baele M. Staphylococcus pseudintermedius versus Staphylococcus intermedius. Veterinary Microbiology 2009, 133:206-7.
14. Stickler DJ. Chlorhexidine resistance in Proteus mirabilis. Journal of Clinical Pathology 1974, 27:284-7.
15. Nakahara H, Kozukue H. Isolation of chlorhexidine-resistant Pseudomonas aeruginosa from clinical lesions. Journal of Clinical Microbiology 1982, 15:166-8.
16. Mills PC, Ahlstrom L, Wilson WJ. Ototoxicity and tolerance assessment of a TrisEDTA and polyhexamethylene biguanide ear flush formulation in dogs. Journal of Veterinary Pharmacology and Therapeutics 2005, 28:391-7.
17. Ghibaudo G, Cornegliani L, Martino P. Evaluation of the in vivo effects of Tris-EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases. Veterinary Dermatology 2004, 15. Abstract
18. Russell A. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. The Lancet Infectious Diseases 2003, 3:794-803.
19. Weber DJ, Rutala WA. Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance? Infection Control and Hospital Epidemiology 2006, 10:1107-19.
20. Yasuda T, Yoshimura S, Katsuno Y. Comparison of bactericidal activities of various disinfectants against methicillin-sensitive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. Postgraduate Medical Journal 1993, 69:66-9.
21. Lloyd DH, Lamport AI. Evaluation in vitro of the antimicrobial activity of two topical preparations used in the management of ear infections in the dog. Veterinary Therapeutics 2000, 1:43-7.
22. Olitzky I. Antimicrobial properties of a propylene glycol based topical therapeutic agent. Journal of Pharmaceutical Sciences 1965, 54:787-8.